Search Results

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial by Mai, Elias K. (Author) , Bertsch, Uta (Author) , Egerer, Gerlinde (Author) , Ho, Anthony Dick (Author) , Hillengaß, Jens (Author) , Raab, Marc-Steffen (Author) , Goldschmidt, Hartmut (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment by Gourzones-Dmitriev, Claire (Author) , Kassambara, Alboukadel (Author) , Sahota, Surinder (Author) , Rème, Thierry (Author) , Moreaux, Jérôme (Author) , Bourquard, Pascal (Author) , Hose, Dirk (Author) , Pasero, Philippe (Author) , Constantinou, Angelos (Author) , Klein, Bernard (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    The NK1 receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma by Egerer, Gerlinde (Author) , Eisenlohr, Kathrin (Author) , Gronkowski, Martina (Author) , Burhenne, Jürgen (Author) , Riedel, Klaus-Dieter (Author) , Mikus, Gerd (Author) ,


    Get full text
    Article (Journal) Online Resource